Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: British Journal of Cancer, 104, 10, S. 1641-1648

Ereignis
Veröffentlichung
(wo)
Augsburg
(wer)
Universität Augsburg
(wann)
2011
Ereignis
Veröffentlichung
(wo)
Edinburgh
(wer)
Springer Science and Business Media LLC
(wann)
2011
Urheber
Bauernhofer, T.
Pichler, Martin
Wieckowski, E.
Stanson, J.
Aigelsreiter, A.
Griesbacher, A.
Groselj-Strele, A.
Linecker, A.
Samonigg, H.
Langner, C.
Whiteside, T. L.

DOI
10.1038/bjc.2011.131
URN
urn:nbn:de:bvb:384-opus4-1057685
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:50 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bauernhofer, T.
  • Pichler, Martin
  • Wieckowski, E.
  • Stanson, J.
  • Aigelsreiter, A.
  • Griesbacher, A.
  • Groselj-Strele, A.
  • Linecker, A.
  • Samonigg, H.
  • Langner, C.
  • Whiteside, T. L.
  • Universität Augsburg
  • Springer Science and Business Media LLC

Entstanden

  • 2011

Ähnliche Objekte (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma

Best of ASCO 2022: bladder cancer

Best of ASCO 2022: bladder cancer

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Inflammation, phagocytosis and cancer: another step in the CD47 act

Inflammation, phagocytosis and cancer: another step in the CD47 act

The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck

The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation

Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation

Verbundene Objekte